sglt2i in different patient groups: effect on ckd progression | natalie staplin, phd
Published 2 months ago • 232 plays • Length 29:46Download video MP4
Download video MP3
Similar videos
-
30:38
the impact of glp-1ra and sglt2i on ckd progression in subjects with diabetes | peter rossing, md
-
9:06
sglt2 inhibitors in chronic kidney disease
-
16:24
how sglt2 inhibitors protect the kidney
-
32:00
role of sglt2 inhibitors in ckd
-
1:00:55
sglt2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease
-
23:14
#12 sglt2i / mras / glp1s, with katherine tuttle
-
10:55
what are sglt2 inhibitors and how do they affect kidney disease?
-
52:33
dr. daniel korpal: stemi equivalents
-
4:10
sglt2i: everything you need to know in 5 minutes
-
28:56
christine limonte, md - update on sglt2i: real-world use and special population
-
35:24
professor david wheeler - 'how do sglt2 inhibitors benefit the kidney?'
-
1:07:45
sglt2i & cardio/renal aspects
-
58:38
nephrology grand rounds: sglt2 inhibitors
-
7:43
choosing sglt2 inhibitors vs glp-1 receptor agonists
-
59:47
nov 2022 - sglt2 inhibition by dapagliflozin mitigates peritoneal fibrosis & ultrafiltration failure
-
3:23
what are sglt2 inhibitors - chronic kidney disease | uhl nhs trust
-
56:43
renal events in patients receiving neprilysin inhibitors: a systematic review and meta-analysis
-
1:02
do sglt2 inhibitors help in preventing kidney disease?
-
49:14
sglt2 inhibitors: can these drugs slow the progression of chronic kidney disease?
-
4:05
association of kidney function with sglt2 inhibitor discontinuation